Curis | CRIS - 销售和管理费用





销售和管理费用 更改 日
Alaunos Therapeutics USD 424K 23K 2026-06
Amgen USD 1.68B 40M 2026-09
AstraZeneca USD 4.07B 1.73B 2026-09
Bayer EUR 4.02B 53M 2026-09
Bristol-Myers Squibb USD 1.7B 127M 2026-09
CSL USD 1.23B 498M 2025-12
Curis USD 2.96M 1.62M 2026-03
Eli Lilly USD 3.12B 305M 2026-09
Exelixis USD 154.56M 6.93M 2026-09
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.16B 39M 2026-09
Incyte USD 364.27M 12.54M 2026-09
Merck USD 2.86B 25M 2026-09
Novartis USD 3.08B 163M 2026-09
Pfizer USD 3.28B 132M 2026-09
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.31B 325M 2026-09
Takeda JPY 271.71B 14.8B 2026-09
TG Therapeutics USD 62.32M 10.82M 2026-06
Verastem USD 22.3M 2.14M 2026-03